Influenza drug, Xofluza, receives expanded approval
by Press Release from Outbreak News Today on (#5ARV9)
By NewsDesk @bactiman63 The U.S. Food and Drug Administration today expanded the approved indication for Xofluza (baloxavir marboxil) to include post-exposure prevention of influenza (flu) for patients 12 years of age and older after contact with an individual who has the flu. Xofluza, previously available only in tablet form, is also now available as granules for [...]
The post Influenza drug, Xofluza, receives expanded approval appeared first on Outbreak News Today.